SS Innovations International, Inc. (NASDAQ: SSII) has been named the Outstanding Company at the 2026 Surgical Robotics Industry Awards, surpassing major competitors including Intuitive Surgical (NASDAQ: ISRG), Johnson & Johnson (NYSE: JNJ), and Medtronic (NYSE: MDT). The award recognizes a single company demonstrating excellence in innovation, commercial success, industry leadership, and positive societal impact.
The achievement underscores SS Innovations' rapid ascent in the surgical robotics field. The company's proprietary "SSi Mantra" surgical robotic system and "SSi Mudra" surgical instruments support a variety of procedures, including cardiac surgery. SS Innovations aims to make robotic surgery affordable and accessible globally, with its U.S. headquarters and operations based in India.
Other finalists included MedTech, MicroPort Scientific (HKEX: 0853), Distalmotion, FUTEK, Meril, Precision IO Group, and THINK Surgical. SS Innovations' win positions it as a disruptive force in a market traditionally dominated by established players.
According to the company, its solutions are technologically advanced, user-friendly, and cost-effective, with plans to expand global presence. The award validates its strategy of democratizing robotic surgery, potentially accelerating adoption in underserved regions.
For more information, visit the company's newsroom at https://ibn.fm/SSII.
